Jun 15, 2022 / 05:00PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Okay. Great. Welcome, everybody. Good morning. I'm Matt Sykes, Life Science Tools and Diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming Agilent this morning. Mike McMullen, Chief Executive Officer; and Bob McMahon, Chief Financial Officer. Mike, Bob, thanks for coming.
Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director
Thanks for having us.
Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO
Our pleasure. Thanks for having us.
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. I think, Mike, we could probably spend the next 20, 30 minutes on Philadelphia Eagles, but I don't think anyone wants to hear that.
Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director
I got those in my Walkman song of Fly, Eagles
Agilent Technologies Inc at Goldman Sachs Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot